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ABSTRACT
Objective: To study the change of TIZ expression in epithelial ovarian cancer cells. Methods:
H08910 cells were transinfected with siRNA to inhibit the expression of TIZ. pcDNA3.1-TIZ
vectors were combined to increase the TIZ expression level. The cell viability, colony forming
efficiency and cycle distribution of H0891O, H089101NC, H0891O/pcDNA3.1-NC, H089101 TIZ-573
and H0891O/pcDNA3.1-TIZ were compared, and the invasion rate, migration rate and adhesion
rate between 5 groups of cells were compared. Results: Compared with those of H0891O, H089101
NC and H08910/pcDNA3.1-NC, the cell viability, colony forming efficiency and cell cycle
distribution of H089101 TIZ-573 were increased, while the indexes of H0891O/pcDNA3.1-NC
were decreased with statistical significant difference (P<O.05). There was no statistical significant
difference in the invasion rate, migration rate and adhesion rate between 5 groups of cells (P>O.05).
Conclusions: The expression of TIZ can inhibit the proliferation of epithelial ovarian cancer
cells.
1. Introduction
The epithelial ovarian tumor is a common malignant
gynecological tumor, occupying 50%-70% of ovarian tumors
[1J. With the advances in the modern cellular and molecular
biology, we have gained a deeper understanding in the
occurrence and development of the epithelial ovarian
cancer. Considerable research has indicated that such a
tumor is the result of a combination of many genes and
factors in different stageslzl, TRAF-6 inhibitory zinc finger
protein (fIZ) belongs to the CzHz-type zinc finger protein
family, which can be combined with the tumor necrosis
factor receptor-associated factor 6 (fRAF-6) to play a role
in the regulatio[3,4J. According to clinical research, the
expression level of TIZ protein in the serum of patients
with ovarian malignant tumor was significantly higher than
the one of patients with ovarian benign tumor and the one
of normal subjects, which indicates the high correlation
between the expression level of TIZ and the ovarian
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cancerl5J. In this study, we observed the expression level of
TIZ gene in epithelial ovarian tumor cells (H0891O) to study
the effect of TIZ on the biological characteristics of tumor
cells.
2. Materials and methods
2.1. Materials and reagents
The epithelial ovarian tumor cells (H0891O) provided by
Shanghai SXBio Biotechnology Co., Ltd. was chosen as
the experimental subject. pGPU6/GFP/Neo interference
vector was provided by Shanghai GenePharma Co., Ltd.
pcDNA3.1 expression vector, TRlzol, propidium iodide (PI),
RPMI 1640 medium and liposome LipofectAMINE™2000
were all purchased from Invitrogen, a brand under the
Life Technologies brand of the Thermo Fisher Scientific
corporation. cDNA synthesis kit was provided by MBI
Fermentas; DNA segment rapid purification recycle kit was
provided by Beijing Sunbiotech Co., Ltd.; E.Z.N.A.® Plasmid
Mini Kit I was provided by Omega Biotek. The fibronectin
(FN), transwell chamber and artificial basement membrane
matrigel were all provided by Coming Costar. Escherichia
coli (E. coli) DH-5 a was preserved in this laboratory.
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2.2. Determination of TIZ expression level in H08910 cell
lines
TRIzol reagent was used to extract mRNA of H08910
cells for the reverse transcription. cDNA amplification was
performed with the reaction system of 25 fL L. The reaction
conditions were the degeneration at 94 ·C for 5 min, at
94 ·C for 1 min, at 5 ·C for 1 min and at 72 ·C for 1 min, 35
times of sequence cycles, extension at 72 ·C for 5 min and
the preservation of product at 4 ·C. The electrophoretic
determination of PCR products was performed using 1%
agarose gel. All the above primers were synthesized by
Sangon Biotech (Shanghai)Co., Ltd.
2.3. Interference ofsmall RNA in TIZ expression
Three segments of small interfering RNA (siRNA)
were designed and synthesized according to the mRNA
sequences of TIZ in GenBank: the upstream segment of
TIZ-554 was 5'-CACCUAACUCGACAUGAAATT-3' and the
downstream one was 5'-UUUCAUGUCGAGUUAGGUGTG-3';
the upstream segment of TIZ-573 was 5'-
GAAAUUAUACCAAGGUGAATT-3' and the downstream
one was 5'- UUCACCUUGGUA UAA UUUCTT-3';
the upstream segment of TIZ-620 was 5'-
GCUGUUAACCAAUCUUCAATT-3' and the downstream
one was 5'-UUGAAGAUIJCCImAACAGCTT-3'.
Negative control (NC): the upstream segment was 5'-
UUCUCCGAACGUCUCACGUTT-3' and the downstream one
was 5'-ACGUGACACGUUCGGAGAATT-3'. All the above
sequences were synthesized by Shanghai GenePharma Co.,
Ltd.
TIZ-554, TIZ-573, TIZ-620 and negative control sequences
were combined with T4-DNA ligase and pGPU6/GFP/Neo
interference vectors respectively. E. coli DH-5 a competent
cells were transformed by products respectively. The
bacterial flora was screened using 100 fL g!uL ampicillin
and it was cultured for amplification. The plasmid was
extracted and PCR and double restriction enzyme digestion
were performed again. The positive recombinant plasmid
was used for bi-directional sequencing of DNA.
H08910 cells were transfected using the recombinant
plasmids of TIZ-554, TIZ-573, TIZ-620 and NC, named as
H0891O/TIZ-554, H0891O/TIZ-573, H08910/TIZ-620 and
H08910/NC respectively. The above cells and untreated
H08910 cells were compared for the expression level of TIZ.
2.4. Upregulation ofTIZ expressionvia in vitro transfection
PCR product and pcDNA3.1 vector were both treated
by double digestion of BamH I and EcoR I and the
products of digestion were separated. Target fragments
were recovered and purified. And the recombinant plasmid
was constructed. T4-DNA ligase was used to combine
the vector and the target gene. E. coli DH-5 a competent
cells were transformed by the product (pcDNA3.1-TIZ).
The extraction and detection of recombinant plasmid were
the same as above. H08910 cells were transfected using
pcDNA3.1-TIZ plasmid and pcDNA3.1 plasmid, named as
H0891O/pcDNA3.1-TIZ cell and H0891O/pcDNA3.1-NC cell
respectively. mRNA of untreated H08910 cells, H089101
pcDNA3.1-TIZ cells and H0891O/pcDNA3.1-NC cells was
extracted respectively and RT-PCR was used to detect the
expression level of TIZ in cells.
2.5. Detection ofcell viability by MTT method
Cells in the logarithmic phase were taken to prepare the
single cell suspension, with a cell density of lx105l mL. A
total of 100 fL L of cell suspension were added in the 24-well
plate, with 3 repeated wells. The control group was set with
100 fL L of medium in each well. A total of 100 fL L of 5 mg!
mL MTT solution was added in each well and incubated at
37 ·C for 4 h. The liquid was removed, 500 fLL DMSO was
added in each well and oscillated for 10 min. Absorbance (A)
value was measured at 450 nm and the growth curve of cells
was drawn.
2.6. Colonyformation assay
Stably transfected cells were chosen to prepare the single
cell suspension. Cells were seeded in the 24-well plate, with
100 cells in each well. The 24-well plate was gently shaken
to achieve the uniform distribution of cells. Cells were put
in the thermotank of 37·C with 5% CO2 volume fraction for
the culture of 5-7 days. After the culture, cells were washed
using PBS. Cells were stained by Giemsa. The number
of colony forming units was counted under the optical
microscope. A total of 15-50 cells were taken as a colony.
The equation was as follows: Colony-forming efficiency (%)
=Number of clones I Number of inoculated cells x 100%.
2.7. Determination of changes in cell cycle using flow
cytometry
Cells were taken in the logarithmic phase to prepare the
single cell suspension. A total of 15 mL of 95% ethanol
solution pre-cooled at -20 ·C was added and fixed at
4 ·C for 1 h. The ethanol solution was removed using the
centrifugal method. The cell density was adjusted to lX1Q6/mL,
digested using 50 fL g/mL RNA enzyme for 2 min and
strained by using 50 fL g!mL PI away from light for 30 min.
The content distribution of DNA was analyzed by using flow
cytometry, as well as the proportion of cells in phases of Gri
Glo G2+M and S. The proportion of cells in the phase of GrlG,
was taken as the indicator to reflect the proliferation ability
of cells.
2.8. Changes in in vitro invasion and migration
Polycarbonate membrane filter of Transwell was treated
using PBS with 5 fL g FN. A total of 50 fL L of 1.25mgl
mL matrigel was added in the upper cavity. The treated
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Table 1
Colony forming efficiency of different cells (mean依sd).
Cell Number of seeded cells Colony forming efficiency (%)
HO8910 100 59.23依4.15
HO8910/NC 100 59.11依4.22
HO8910/pcDNA3.1-NC 100 58.88依3.97
HO8910/ TIZ-573 100 84.12依7.45
HO8910/pcDNA3.1-TIZ 100 41.55依2.43
TIZ expression
H08910       H08910/NC      H08910/         H08910/        H08910/  
TIZ-554         TIZ-573         TIZ-620
TIZ expression
H08910            H08910/pcDNA3.1-NC  H08910/PCDNA3.1-TIZ
- l i l -
Transwell was incubated at 37 ·C for 4-5 h. The cell
suspension was added in the upper and lower cavity. After
24 h, MTT method was used to detect D value of adhesion
cells in upper and lower cavities at 450 nm. The equation
was as follows:Invasion rate (%) = D450nm of Cells in lower
cavity/D4511nmof cells in upper cavity X 100% [61.
Except the addition of matrigel, the determination of in
vitro migration was similar with the in vitro invasion assay.
Migration rate (%) =D450nm of cells in lower cavity/D4511nmof
cells in upper cavity X 100%[6].
2.9. Changes in in vitroadhesionability
•
+ r+
r+ iF-
+
1 1 1
- -
Figure 1. Expression level of TIZ in different cells,
Figure 2. Expression level of TIZ in different cells,
3.2. T1Zexpression in pcDNA3.1-TIZ transJected cells
There was no statistical difference in the TIZ expression
between R08910 and R08910/pcDNA3.1-NC (P>0.05),
but TIZ expression in R0891O/pcDNA3.1-TIZ cells was
significantly increased (p<0.05), as shown in Figure 2.
rl-
+ rl-
O/pc 3.I O I
Statistical analysis was performed by using SPSSI5.0. The
measurement data were expressed as mean±sd. The one-
way ANOVA was used to analyze the difference between
groups, while the analysis of variance with repeated
measures was used in comparison of cell viability at
different times, P<0.05 indicating the statistical significant
difference.
2.10. Statisticalanalysis
The 96-well plate was taken, and 50 f1. L of 20 mgIL FN was
added in each well, allowing it to air dry on the clean bench
over the night, and then the plate was put in the refrigerator
at 4 ·C. Before using, it was used by PBS twice. The binding
site was closed, the cell suspension was added, cultured for
1 h and washed by PBS to remove the unadbered cells. MTT
method was used to detect D value of adhesion cells in upper
and lower cavities at 450 nm. Adhesion rate (%) =D450nm of
adhesion cells in experiment group/D450nm of adhesion cells
in control group X 100%[61. Repeat the procedures (2.4-2.8)
for three times.
3.3. EffectoJTIZ expression on cellviability
3. Results
3.1. Determination ojsiRNA interference efficiency
Compared with NC sequence transfected cells, the
expression level of TIZ in three siRNA transfected fragments
of TIZ-554, TIZ-573 and TIZ-620 was significantly
decreased (P<0.05); the expression level of TIZ in TIZ-573
transfected cells was significantly lower than others (P<0.05).
There was no statistical difference in the expression level of
TIZ between R08910/NC and R08910 (p>0.05), as shown in
Figure 1.
TIZ-573siRNA fragments with the best interference
effect were chosen for the study. There was no statistical
difference in the cell viability between R0891O, R089101
NC and R0891O/pcDNA3.1-NC (P>0.05). The cell viability
of R089101 TIZ-573 was significantky increased, while the
one of R0891O/pcDNA3.1-TIZ was significantly decreased
(P<0.05), as shown in Figure 3.
3.4. EffectoJTIZ expression on colonyforming efficiency
There was no statistical difference in the colony forming
efficiency between R089IO, R08910/NC and R089101
i ± ).
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0
0
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Table 2
Cell cycle of different cells (mean依sd, %).
Cell G0/G1 G2+M S
HO8910 47.22依5.18 31.66依3.55 24.58依2.17
HO8910/NC 48.12依5.01 27.98依3.14 25.55依2.09
HO8910/pcDNA3.1-NC 48.85依5.52 29.13依3.35 23.82依2.23
HO8910/ TIZ-573 35.67依3.38 24.45依2.35 41.24依5.64
HO8910/pcDNA3.1-TIZ 65.88依7.02 17.54依1.97 18.65依1.88
Table 3
In vitro invasion, migration and adhesion of different cells (mean依sd, %).
Cell Invasion rate Migration  rate Adhesion  rate
HO8910 45.25依4.87 53.16依5.13 64.62依7.65
HO8910/NC 45.82依4.47 55.42依5.67 65.53依7.43
HO8910/pcDNA3.1-NC 44.72依4.85 54.76依5.44 63.88依6.92
HO8910/TIZ-573 47.71依5.02 56.82依5.65 67.03依8.22
HO8910/pcDNA3.1-TIZ 44.12依4.28 52.97依5.21 63.37依7.14
H08910
H08910/NC
H08910/pcNDA3.1-NC
H08910/TIZ-573
H08910/pcDNA3.1-TIZ
1.2
1.0
0.8
0.6
0.4
0.2
0.0
1 d       2 d      3 d       4 d       5 d       6 d      7 d
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Figure 3. Growth curves of different cells.
4. Discussion
indicates the high correlation between the expression level
of TIZ and the ovarian cancer. In this study, we used siRNA
to interfere with the expression level of TIZ in R089IO
and then constructed the expression vector to increase the
expression level of TIZ. Relying on the in vitro experiment,
we studied the effect of change in the expression level of TIZ
on the biological characteristics of epithelial ovarian tumor
cells (R089IO).
In the study, compared with that in transfected cells of
NC sequence, the TIZ expression in three segments of cells
transfected by siRNA, namely TIZ-554, TIZ-573 and TIZ-
620, was significantly decreased, while the transfection
efficiency of TIZ-573 was the highest; the TIZ expression
in R089IO/pcDNA3.I-TIZ cell was significantly increased,
which indicates the success of interference in the TIZ
expression in R089IO.
TIZ-573siRNA segment with the best interference effect
was selected for the further study. The cell viability, colony
forming efficiency and cell cycle of R089IO, R089IO/NC,
R089IO/pcDNA3.I-NC, R089101 TIZ-573 and R089IOI
pcDNA3.I-TIZ were compared and then the proliferation
ability of different cells was evaluated. Compared with that
of R089IO, R089IO/NC and R089IO/pcDNA3.I-NC, the cell
viability of R089IOI TIZ-573 was increased, as well as the
colony forming efficiency and the number of cells in the
phase of Gc!Gj ; while the cell viability of R089IO/pcDNA3.1-
TIZ was decreased, as well as the colony forming efficiency
and the number of cells in the phase of Gc!Gj • It indicates
that the expression of TIZ inhibits the proliferation of
epithelial ovarian cancer cells. TIZ is just like the hospital
of zinc finger protein KRAB family. Such kind of protein
all plays a critical role in the embryonic development,
transformation and differentiation of cells and the regulation
of cell cycles[7,8J. The mechanism for TIZ to inhibit the
proliferation of tumor cells has not been clear, but some
research has indicated that it can effectively inhibit the
TRAF-6 mediated signal transduction. It combines with N
terminal of TRAF-6 to change the protein conformation of
TRAF-6 and then blocks the transduction of downstream
signalslsl. The TRAF-6 mediated signal transduction is
Y -- 02 _ . 0Z~ _'t" . -
_ . or·
I
1.2_ - - - - - - - - - - - .....
o o "-- ---~-~-~-----"
~ O
. .. · l
-~ l e 1.0
-- omz-57
- l e
There was no statistical difference in the percentage of
cells in different phases between R089IO, R089IO/NC and
R089IO/pcDNA3.I-NC (p>0.05). Cells of R089IOI TIZ-573
in the phase of Gc!G1 were significantly increased, while
cells of R089IO/pcDNA3.I-TIZ in the phase of Gc!G j were
significantly decreased (P<0.05), as shown in Table 2.
pcDNA3.I-NC (P>0.05). The colony forming efficiency
of R089IOI TIZ-573 cell was increased, while the one
of R089IO/pcDNA3.I-TIZ cell was decreased, with the
statistical difference (P<0.05), as shown in Table I.
There was no statistical difference in the in vitro invasion
rate, migration rate and adhesion rate between R089IO,
R089IO/NC, R089IO/pcDNA3.I-NC, R089IOI TIZ-573 and
R089IO/pcDNA3.I-TIZ (p>0.05), as shown in Table 3.
3.5. Effect oJTIZ expressionon cell cycle
According to the clinical studies, the expression level of
TIZ protein in the serum of patients with ovarian malignant
tumor was significantly higher than the one of patients with
ovarian benign tumor and the one of normal subjects, which
3.6. Effect of TIZ expression on in vitro invasion, migration
and adhesion ojcells
l
l lls ±
s
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0 IOI
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relatively complicated, mainly including two ways[lO): (1)
TRAF-6--+mitogen-activated protein kinase kinase (MAPKK)
--+mitogen-activated protein kinase (MAPK); (2)TRAF-6
--+MAPKK--+nuclear factor KB (NF- Ie B). The downstream
signal proteins involved in the above two ways, such as INK,
P38, ERKI/2, C-FOS and NF- Ie B, are all closely related to
the occurrence and development of ovarian cancer[1l,12J. By
blocking the TRAF-6 mediated signal transduction, TIZ can
significantly inhibit the expression of the above proteins and
thus inhibit the proliferation of epithelial ovarian cancer
cells (H0891O).
In this study, there was no statistical difference in the
invasion rate, migration rate and adhesion rate between
H08910, H08910/NC, H0891O/pcDNA3.1-NC, H089101
TIZ-573 and H0891O/pcDNA3.1-TIZ, which indicates that
there is no significant effect of TIZ expression on the in
vitro invasion, migration and adhesion of epithelial ovarian
cancer cells. The invasion ability of ovarian malignant
tumor was relatively strong. 76% diagnosed patients had a
wide migration of the abdominal cavity, the pelvic plant
and the liver substance or the pleura and the brain[13J. The
migration is the result of combination of cell adhesion and
new blood vessels. Presently, there has been no definite
conclusion on the correlation between TIZ expression
and the spread and migration of epithelial ovarian tumor.
Some research indicated that in the TIZ-mediated signal
transduction, there was a high correlation between the cell
factors of lysophosphatidic acid, matrix metalloproteinases,
urokinase-type plasminogen activator, vascular endothelial
growth factor and intercellular adhesion molecule and
the invasion and migration of ovarian cancer[14,15J. The
downstream signal molecules of TIZ expression had a
negative feedback to the expression of TIZ, which then
decreased the expression level of TIZ and weakened the
inhibition ability; the decrease in the expression level of TIZ
would also inhibit the activation of downstream signaling
pathways to deactivate the signal molecules related to
the invasion and migration of tumor and then decrease
its invasion ability[16,17J. Anyway, TIZ possesses the dual-
direction regulation on the invasion ability of H0891O. In
conclusion, this study indicates that TIZ expression can
inhibit the proliferation of epithelial ovarian tumor, but has
no obvious effect on the invasion ability of tumor.
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